Ventas, Inc. logo VTR - Ventas, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 18
HOLD 12
SELL 2
STRONG
SELL
0
| PRICE TARGET: $96.29 DETAILS
HIGH: $110.00
LOW: $88.00
MEDIAN: $96.50
CONSENSUS: $96.29
UPSIDE: 0.20%

Stock News

Here Are Tuesday’s Best Wall Street Analyst Research Calls: Adobe, American Airlines, Broadcom, First Solar, Meta Platforms, Shopify, Space-X, Ventas, Waste Managment, and More

Here Are Tuesday’s Best Wall Street Analyst Research Calls: Adobe, American Airlines, Broadcom, First Solar, Meta Platforms, Shopify, Space-X, Ventas, Waste Managment, and More

Pre-Market Stock Futures: Futures are trading mixed, with the Nasdaq getting hammered after a gangbuster start to the first full trading week of the third quarter. All of the major indices finished the day higher, with chip stocks once again leading the way. When the dust settled at the close, the Nasdaq finished the day... Here Are Tuesday's Best Wall Street Analyst Research Calls: Adobe, American Airlines, Broadcom, First Solar, Meta Platforms, Shopify, Space-X, Ventas, Waste Managment, and More

Jul 07, 2026 04:00 AM 247wallst.com
Ventas Announces Second Quarter 2026 Earnings Release Date and Conference Call

Ventas Announces Second Quarter 2026 Earnings Release Date and Conference Call

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) will issue its second quarter 2026 earnings release after the close of trading on the New York Stock Exchange on Wednesday, July 29, 2026. A conference call to discuss those earnings will be held on Thursday, July 30, 2026 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in number for the conference call is (888) 330-3576 (or +1 (646) 960-0672 for international callers), and the participant passcode is 7655497. A live webcast can b.

Jun 29, 2026 12:15 PM businesswire.com
Ventas Names Andrew L. Wattula EVP Outpatient Medical & Research

Ventas Names Andrew L. Wattula EVP Outpatient Medical & Research

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that the Company has named Andrew L. Wattula Executive Vice President, Outpatient Medical & Research and CEO of Lillibridge Healthcare Services, a wholly-owned property management and leasing subsidiary of Ventas, effective August 2026. He will oversee the Company's differentiated outpatient medical and research business, which is a leading owner and manager of properties operating at the intersec.

Jun 22, 2026 01:56 PM businesswire.com
Ventas Chairman and CEO Debra A. Cafaro to Receive Cyrus McCormick Making History Award for Historic Corporate Achievement

Ventas Chairman and CEO Debra A. Cafaro to Receive Cyrus McCormick Making History Award for Historic Corporate Achievement

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) today announced that Chairman and Chief Executive Officer Debra A. Cafaro will receive the Cyrus McCormick Making History Award for Historic Corporate Achievement at the Chicago History Museum's 32nd Annual Making History Awards this evening. The Cyrus McCormick Making History Award for Historic Corporate Achievement recognizes business leaders and organizations whose work has made enduring contributions to Chicago's economic and civic life. Un.

Jun 03, 2026 12:21 PM businesswire.com
Ventas Issues Business Update and Will Participate in Investor Meetings at Nareit's REITweek 2026 Investor Conference

Ventas Issues Business Update and Will Participate in Investor Meetings at Nareit's REITweek 2026 Investor Conference

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that it has issued an investor presentation, which is available on the Company's website at ir.ventasreit.com/events-and-presentations. Company management will participate in investor meetings at Nareit's REITweek 2026 Investor Conference. About Ventas Ventas, Inc. (NYSE: VTR) is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With more than.

Jun 01, 2026 12:15 PM businesswire.com
U.S. REIT At-The-Market Activity Dips In Q1 2026

U.S. REIT At-The-Market Activity Dips In Q1 2026

Thirty-three US REITs utilized their at-the-market (ATM) offering programs during the recent quarter, raising $4.15 billion in aggregate proceeds. Healthcare REIT Welltower Inc. raised the most capital during the first quarter, selling nearly 7.7 million shares of common stock through its ATM program for $1.56 billion in gross proceeds. In the aggregate, healthcare REITs raised $2.67 billion through their ATM programs during the first quarter, the most of any property sector. The data center REIT sector was next with $875.0 million.

May 27, 2026 11:55 PM seekingalpha.com
Ventas Declares Quarterly Dividend of $0.52 Per Common Share

Ventas Declares Quarterly Dividend of $0.52 Per Common Share

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) today announced that its Board of Directors has declared a quarterly dividend of $0.52 per common share. The dividend will be payable in cash on July 16, 2026, to stockholders of record as of the close of business on June 30, 2026. About Ventas Ventas, Inc. (NYSE: VTR) is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With more than 1,400 properties in North America and the United Kin.

May 13, 2026 12:30 PM businesswire.com
REITs Excel, Earnings Swell, Fed Rebels

REITs Excel, Earnings Swell, Fed Rebels

U.S. equity markets advanced for a fifth straight week - their longest winning streak since 2024 - as strong earnings, resilient data, and hopes for lasting Iran peace fueled optimism. Investors looked through another oil-price surge and inflationary pressure, focusing instead on corporate resilience and economic strength despite a complex macro backdrop shaped by geopolitical and policy uncertainty. The Fed held rates steady in an unusually fractured 8-4 vote, while Powell's plan to remain on the Board broke precedent and raised politically charged succession questions.

May 03, 2026 05:00 AM seekingalpha.com

Price Targets